Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Pivotal study for PW-2102 meets primary endpoint

March 29, 2004

Fluvastatin XL reduces coronary artery disease risk factor in diabetic patients

March 26, 2004

Exercise and metformin improve cardiovascular parameters in HIV-infected patients

March 25, 2004

Novartis claims aldosterone synthase inhibitors and their use

March 25, 2004

HGF enters clinic in Japan

March 22, 2004

Washington Hospital, Texas Heart Institute complete Angiogenix studies

March 22, 2004

Y-27632 inhibits K+- and NE-induced arterial contraction with greater effects seen in SHR

March 22, 2004

Promising effects found with ABT-578-eluting stents in de novo coronary lesions

March 19, 2004

Clinical evidence of the efficacy of Caduet in hypertension and high cholesterol

March 19, 2004

A-HeFT trial of BiDil cleared to continue by DSMB

March 18, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...